Terminated PHASE4 INTERVENTIONAL 2-arm NCT00569465

N-Acetylcysteine and Arginine Administration in Diabetic Patients (NACARGPAO)

Effects of Arginine and N-Acetylcysteine Administration on Nitric Oxide Production and Arterial Blood Pressure in Hypertensive Diabetic Patients.

Sponsor: University of Turin, Italy

Conditions Hypertension Type 2 Diabetes Mellitus

Interventions Acetylcysteine Arginine Placebo

Updated 4 times since 2017 Last updated: Dec 6, 2007 Started: Jan 31, 2005 Completion: Jan 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

End of the study

Other terminated trials from University of Turin, Italy

See all terminations from University of Turin, Italy

Other Hypertension trials with similar outcome

Browse all Hypertension trials

Listed as NCT00569465, this PHASE4 trial focuses on Hypertension and Type 2 Diabetes Mellitus and remains terminated or withdrawn. Sponsored by University of Turin, Italy, it has been updated 4 times since 2005, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE4
Jan 2017 — Jan 2021 [monthly]

Terminated PHASE4

First recorded

Jan 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Turin, Italy

Data source: University of Turin, Italy

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Turin, Italy